Ridgepost Capital Reports Fourth Quarter and Full Year 2025 Earnings Results
RADIENT PHARMACEUTICALS (RPC)
Company Research
Source: GlobeNewswire
Record Full Year Fundraising and Deployment of $5.1 Billion Fee-Paying AUM increased 15% year over year DALLAS, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Ridgepost Capital, Inc (NYSE: RPC) (“Ridgepost Capital” or the “Company”), a leading private markets solutions provider, today reported financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Revenue: $81.0 million compared to $85.0 million in the prior year.Fee-Related Revenue: $81.0 million compared to $85.0 million in the prior year.Fee-Paying Assets Under Management: $29.4 billion, a 15% increase year over year.GAAP Net Income: $11.0 million compared to $5.7 million in the prior year.Fee-Related Earnings: $39.0 million compared to $42.7 million in the prior year.Adjusted Net Income: $30.2 million compared to $35.3 million in the prior year.Fully Diluted GAAP EPS: $0.09 compared to $0.05 in the prior year.Fully Diluted ANI per share: $0.26 compared to $0.30 in the
Show less
Read more
Impact Snapshot
Event Time:
RPC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RPC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RPC alerts
High impacting RADIENT PHARMACEUTICALS news events
Weekly update
A roundup of the hottest topics
RPC
News
- Ridgepost Capital (RPC) had its price target lowered by Barclays PLC from $12.00 to $11.00. They now have an "overweight" rating on the stock.MarketBeat
- P10 (NYSE:RPC) is now covered by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>. They set a "hold (c)" rating on the stock.MarketBeat
- P10 (NYSE:RPC) had its price target lowered by analysts at Barclays PLC from $13.00 to $11.00. They now have an "overweight" rating on the stock.MarketBeat
- P10 (NYSE:RPC) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.MarketBeat
- P10 Renamed Ridgepost CapitalGlobeNewswire